Tag: phase 3 trial
January 15, 2020
Kala Announces Enrollment Completion of Trial for Dry Eye Disease
Kala has completed enrollment in its Phase 3 clinical trial for its product candidate for the short-term treatment of dry...
January 14, 2020
Neptune Reveals Acasti Share Sale After Failed Drug Study
Neptune said the months-long sale generated US$4 million in net proceeds, a move geared at monetizing the firm’s non-core investments. October 2, 2019
Soleno Therapeutics Announces Data from Second Planned Data Safety Monitoring Board Review
The outcome of the second meeting was based off data from more than 50 percent of enrolled and treated patients. September 30, 2019
Acasti Pharma Releases Additional Phase 3 Milestones
The company said that almost 80 percent of the patients in the Phase 3 TRILOGY trial have completed randomization in... September 19, 2019
Rafael Pharma Expands Phase 3 Trial into South Korea
The clinical trials will kick off with an investigator meeting held on Sept. 19 in Seoul. The study is also...
August 19, 2019
Nabriva Notches First FDA Nod for Pneumonia Treatment
The FDA's approval of Xenleta is the first of its kind in almost two decades and will treat community-acquired bacterial... March 6, 2019